Israeli Company Creates Successful Blood Test for Lung Cancer | IFCJ
Skip Navigation

Israeli Company Creates Successful Blood Test for Lung Cancer

lung xray (Photo: flickr/pulmonary_pathology)

A new Israeli test for lung cancer allows doctors to catch the disease while patients still have a good chance of recovery.

The Israeli company Savicell has developed a successful blood test for lung cancer, allowing the disease to be detected and treated in its earliest stages, thus boosting the chances of recovery.

Dr. Shafrira Shai — the development and production manager of Savicell — was quoted by the Hebrew news outlet Mako as saying, “This process in fact identifies the energetic profile of the cells created as a result of their specific reactions. This gives us exact information on the condition of the person, if he’s in pre-cancerous condition, the beginning stages of cancer, or other possibilities.”

Eyal Davidovitch — the company’s vice president of operations — emphasized the importance of the new test.

“Statistics indicate that if you discover lung cancer in an early stage, the chances of recovery wander on average between 50-80 percent,” he said. “If you identify it at a late stage, we’re talking about four percent — it’s unbelievable. Lung cancer is the number one killer.”

Tags: Israeli Innovation

Previous Post

Next Post

Landscape photo of Jerusalem with the Dome of the Rock in the foreground.

Visit Israel

Here you’ll find an array of useful information on accommodations, transportation, exchanging currency, Israel's climate and customs, and much more. So get the most out of your trip to Israel with the help of The Fellowship.

Read More

About The Fellowship (IFCJ)

The International Fellowship of Christians and Jews (IFCJ) funds humanitarian aid to the needy in Israel and in Jewish communities around the world, promotes prayer and advocacy on behalf of the Jewish state, and provides resources that help build bridges of understanding between Christians and Jews.

Read More